Regeneron New Investigator Awards (formerly the Milstein Young Investigator Awards) at Cytokines 2021 Virtual Meeting – The 9th Annual Meeting of the International Cytokine & Interferon Society [READ MORE]
Since the first report of SARS-CoV-2 from Wuhan, back in December 2019, the pandemic has ravaged the world with ever-evolving different variants-with changing dominance patterns. Different variant of concerns (alpha, beta, gamma, delta and kappa) with corresponding spike mutations, rendering evasion of the immune system and making them varyingly resistant to different vaccines (1). Presently, the delta variant (B.1.617.2) has outcompeted the other variants of concern and is globally the most intimidatingly dominant one. [READ MORE]
Announcing the Cytokines 2021 Virtual Meeting Milstein Abstract Award Winners Powered By EmbedPress Announcing the Cytokines 2021 Virtual Meeting EFIS Trainee Abstract Awards European Federation of Immunological Societies and the European Journal of Immunology Travel/Abstract Awards Available for trainees and postdoc presenters who are currently working in Europe or the UK. [READ MORE]
Congratulations to Biological Sciences Professor Elina Zúñiga on being elected to the 2021 class of fellows of the American Academy of Microbiology. [READ MORE]
Virtual seminars in immunology. Launched by Carla Rothlin and Elina Zúñiga. [READ MORE]
We welcome these new members to the ICIS and we look forward to their attendance at the annual meeting and involvement in the society. The ICIS Membership Committee and Council especially thanks the Sponsoring Members and Research Advisors noted below. As of October 1, 2022, there are 970 ICIS Members in [READ MORE]
By Supreet Agarwal Cytokines represent the major class of all the soluble ligands targeted by FDA-approved drugs Major cytokines’ (interferons, interleukins and chemokines) targeted therapies Figures adapted from: Attwood, M.M., Jonsson, J., Rask-Andersen, M. et al. Soluble ligands as drug targets. Nat Rev Drug Discov 19, 695–710 (2020). https://doi.org/10.1038/s41573-020-0078-4 Cytokines based therapies approved in [READ MORE]
Maryam Mukhamedova, PhD
Post-Doctoral Fellow
Vaccine Research Center, NIAID, NIH, USA [READ MORE]
James Turkson, PhD (Chair of Cytokines 2022 in Hawaii)
Professor, Department of Medicine, Division of Medical Oncology
Associate Director of Strategic Partnerships
Cedars-Sinai Medical Center, Los Angeles, CA USA [READ MORE]
Wei Chen, PhD
Postdoctoral Fellow
NIH/NCI
Rockville, MD USA [READ MORE]
International Cytokine & Interferon Society, Copyright 2024 Website Design by Rhema Association Management | Privacy Policy
